Anders Ettrup

7PUBLICATIONS
25CO-AUTHORS
Epidemiological methodsGene and molecular therapyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial.

|Mar 26, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial.

Rigmor Højland Jensen, Christofer Lundqvist, Henrik W Schytz

|Nov 22, 2025
Long-term tolerability and effectiveness of eptinezumab in Japanese adults with chronic migraine: results of the 60-week open-label SUNSET trial.

Takao Takeshima, Daisuke Danno, Noboru Imai

|Oct 15, 2025
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial.

Shengyuan Yu, Yasuhiko Matsumori, Byung-Kun Kim

|Nov 06, 2024
Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial.

Anna Gryglas-Dworak, Jack Schim, Anders Ettrup

|Nov 02, 2023
Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial.

Xue-Ning Li, Hong-Rong Xu, Ellen Cui

Pageof 2

Frequent Collaborators

3 joint publications

Aurélia Mittoux

2 joint publications

Richard B Lipton

2 joint publications

Anna Gryglas-Dworak

2 joint publications

Gisela M Terwindt